Contact this trialFirst, we need to learn more about you.
Guanylate Cyclase-C Agonist
Linaclotide for Chronic Constipation in Type 2 Diabetes
Recruiting2 awardsPhase 4
El Paso, Texas
This trial has two phases. In the first phase, patients are randomly assigned to receive either the active drug or a placebo for 14 days. In the second phase, the order is reversed. There is a 2-week break in between phases during which patients do not receive any medication. The trial is closely monitored for safety.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.